Kamada (KMDA) Revenue Growth (1y) (2013 - 2026)
Kamada (KMDA) Revenue Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.15 Bn | 87.28 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.89 Bn | 32.15 Bn | 1.97 Bn | 2.34% |
| 3 | Zoetis | 32.49 Bn | 30.55 Bn | 1.62 Bn | 2.91% |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.50 Bn | 4.39 Bn | -11.85% |
| 5 | United Therapeutics | 23.20 Bn | 21.05 Bn | 648.10 Mn | -1.62% |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - | - |
| 7 | Viatris | 20.28 Bn | 18.48 Bn | 1.16 Bn | 7.85% |
| 8 | Neurocrine Biosciences | 17.74 Bn | 16.43 Bn | 800.70 Mn | 42.25% |
| 9 | Elanco Animal Health | 12.58 Bn | 12.15 Bn | 785.00 Mn | 14.92% |
| 10 | Kamada | 400.93 Mn | 327.78 Mn | 19.12 Mn | 2.78% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.78% |
| Dec 31, 2025 | 14.54% |
| Sep 30, 2025 | 12.63% |
| Jun 30, 2025 | 5.37% |
| Mar 31, 2025 | 16.65% |
| Dec 31, 2024 | 7.06% |
| Sep 30, 2024 | 10.03% |
| Jun 30, 2024 | 113,331.08% |
| Mar 31, 2024 | -99.88% |
| Dec 31, 2023 | -19.82% |
| Sep 30, 2023 | -99.88% |
| Jun 30, 2023 | 58.72% |
| Mar 31, 2023 | 109,215.49% |
| Dec 31, 2022 | 44.39% |
| Sep 30, 2022 | 139,767.15% |
| Jun 30, 2022 | -2.68% |
| Mar 31, 2022 | 12.82% |
| Dec 31, 2021 | -0.23% |
| Sep 30, 2021 | -34.79% |
| Jun 30, 2021 | -26.75% |